Amiglyde-V Intrauterine Solution, 250mg/mL

Supplied By: Zoetis (10004013)


SKU
004110


Unit of
Measure
48mL


Pack
Type
Vial


Case
Qty
24

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Dec- 2024 Nov- 2024 Oct- 2024 Sep- 2024 Aug- 2024 Jul- 2024 Jun- 2024 May- 2024 Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024 Dec- 2023
{{purchaseHistoryItem}}


SKU
004110


Size
48mL

Case
Qty
24

Purchase History

Dec- 2024 {{productPurchaseHistory['004110'][0]}} May- 2024 {{productPurchaseHistory['004110'][0+7]}}
Nov- 2024 {{productPurchaseHistory['004110'][1]}} Apr- 2024 {{productPurchaseHistory['004110'][1+7]}}
Oct- 2024 {{productPurchaseHistory['004110'][2]}} Mar- 2024 {{productPurchaseHistory['004110'][2+7]}}
Sep- 2024 {{productPurchaseHistory['004110'][3]}} Feb- 2024 {{productPurchaseHistory['004110'][3+7]}}
Aug- 2024 {{productPurchaseHistory['004110'][4]}} Jan- 2024 {{productPurchaseHistory['004110'][4+7]}}
Jul- 2024 {{productPurchaseHistory['004110'][5]}} Dec- 2023 {{productPurchaseHistory['004110'][5+7]}}
Jun- 2024 {{productPurchaseHistory['004110'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

Amiglyde-V® is indicated for the treatment of uterine infections (endometritis, metritis and pyometra) in mares, when caused by susceptible organisms including Escherichia coli, Pseudomonas sp and Klebsiella sp. The use of Amiglyde-V in eliminating infections caused by the above organisms has been shown clinically to improve fertility in infected mares.

Features & Benefits

  • Plasma protein binding of sulfadimethoxine is high, creating a drug reservoir in the blood that maintains higher blood levels than most other long-acting sulfonamides
  • A single, daily dose gives rapid and sustained therapeutic blood levels for 24 hours
  • Daily dosing increases likelihood of compliance, potentially improving outcomes
  • Available as a tablet and a palatable custard-flavored suspension that eases administration